Skip to main content
logo
Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
7.83
-0.29 (-3.57%)
At close: Sep 12, 2025, 4:00 PM EDT
7.98
+0.15 (1.92%)
After-hours: Sep 12, 2025, 5:05 PM EDT

Gyre Therapeutics Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Gyre Therapeutics stock has a target of 18, which predicts a 129.89% increase from the current stock price of 7.83.

Price Target: $18 (+129.89%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$18$18$18$18
Change+129.89%+129.89%+129.89%+129.89%

Analyst Ratings

According to 1 stock analyst, the rating for Gyre Therapeutics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingSep '25
Strong Buy1
Buy0
Hold0
Sell0
Strong Sell0
Total1

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Matthew Keller
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$18
Strong BuyInitiates$18+129.89%Aug 26, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
125.21M
from 105.76M
Increased by 18.39%
Revenue Next Year
185.64M
from 125.21M
Increased by 48.26%
EPS This Year
0.12
from 0.05
Increased by 154.59%
EPS Next Year
1.19
from 0.12
Increased by 875.00%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
102.29M113.45M105.76M125.21M185.64M247.89M
Revenue Growth
-10.91%-6.78%18.39%48.26%33.53%
EPS
0.03-1.410.050.121.191.75
EPS Growth
---154.59%875.00%47.01%
Forward PE
---63.976.564.46
No. Analysts
---333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202520262027
High131.8M249.9M
Avg125.2M185.6M
Low117.6M123.5M

Revenue Growth

Revenue Growth202520262027
High
24.6%
99.6%
Avg
18.4%
48.3%
Low
11.2%
-1.4%

EPS Forecast

EPS202520262027
High0.131.23
Avg0.121.19
Low0.121.15

EPS Growth

EPS Growth202520262027
High
162.1%
903.7%
Avg
154.6%
875.0%
Low
144.6%
836.8%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.